SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock investors acquired 1,200 call options on the company. This is an increase of 1,438% compared to the average daily volume of 78 call options.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in SIGA. Wellington Management Group LLP lifted its position in shares of SIGA Technologies by 7.2% during the 4th quarter. Wellington Management Group LLP now owns 120,225 shares of the company’s stock worth $723,000 after buying an additional 8,028 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of SIGA Technologies by 28.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 134,382 shares of the company’s stock valued at $808,000 after purchasing an additional 29,442 shares in the last quarter. State of Wyoming increased its position in shares of SIGA Technologies by 163.5% during the 4th quarter. State of Wyoming now owns 45,668 shares of the company’s stock worth $274,000 after purchasing an additional 28,339 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of SIGA Technologies during the 4th quarter worth about $83,000. Finally, ProShare Advisors LLC lifted its holdings in SIGA Technologies by 26.6% during the 4th quarter. ProShare Advisors LLC now owns 16,424 shares of the company’s stock valued at $99,000 after purchasing an additional 3,455 shares during the last quarter. Institutional investors and hedge funds own 55.40% of the company’s stock.
SIGA Technologies Stock Performance
NASDAQ:SIGA opened at $5.50 on Thursday. The firm’s 50-day moving average is $5.81 and its 200-day moving average is $6.41. The company has a market cap of $392.90 million, a price-to-earnings ratio of 4.58 and a beta of 0.98. SIGA Technologies has a 52-week low of $5.16 and a 52-week high of $12.83.
About SIGA Technologies
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Articles
- Five stocks we like better than SIGA Technologies
- What is a buyback in stocks? A comprehensive guide for investors
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- 3 Warren Buffett Stocks to Buy Now
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Why is the Ex-Dividend Date Significant to Investors?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.